Law firm probes Select Medical $16.50/share buyout, questions fairness amid $19 analyst target

Kaskela Law is investigating the proposed $16.50 per share buyout of Select Medical Holdings Corp. announced in March 2026. The firm questions whether this price fairly compensates shareholders, noting at least one analyst had a $19 price target at the time of the announcement. If the buyout proceeds, Select Medical shares will be delisted and shareholders cashed out. Investors who believe the offer undervalues their shares are encouraged to contact Kaskela Law for a free consultation on their legal options.